|
|
| MRD / Regn No. |
: THBC\23-24\01837 |
Date |
: 08/06/2026 |
| Patient Name |
: Vidhya Srinivas |
Age & Gender |
: 48 Yrs. / Female |
| Contact No. |
: 9920020114 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (16/Mar/2016) | |
|
Subjective |
: |
TYPE 2 DM 7-8 YEARS,DYSLIPIDEMIA,? STROKE IN 2022 - NEUROLOGIST,WORK PRESSURE SEVERE - STOPPED EXERCISE / COULD NOT TAKE CARE OF DIET / SOLE EARNING MEMBER,INSULIN CONSIDERED BUT NOT READY,ADDING TRULICITY,FEB 25,FBS-164/HBA1C-9.8
|
|
Objective |
: |
JUNE 2026,HB-14.8,HBA1C-8.3,TC-188/TG-187/LDL-107/HDL-60.3,CR-0.63,AST-24/ALT-27,ACR-< 30,FT3-.75/FT4-1.23/TSH-3.547,CORTISOL MOR-17.69,VIT B1-493,VIT D3-53.4,AMYLASE-115,LIPASE-32 |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
UPRISE D3 60,000 UNITS |
ORAL |
ONCE IN 15 DAYS |
ANYTIME OF DAY
|
3 MTHS |
|
|
2 |
ECOSPRIN AV 75+20 |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
3 |
TABLET DEXLANSOPRAZOLE
DDR 60 MG |
ORAL |
1-0-0 |
BBF
|
30 DAYS |
|
|
4 |
DAPAVEL M 10+500 MG |
ORAL |
1-0-0 |
BBF
|
3 MTHS |
|
|
5 |
TRULICITY 0.75 MG |
SC |
WEEKLY |
|
2 WEEKS |
|
|
6 |
INJECTION DULAGLUTIDE 1.5 MG (INJ)
TRULICITY 1.5 MG |
SQ |
1/WEEK |
WITHIN 30 MINS OF BREAKFAST
|
6 WEEKS |
|
|
7 |
GLIMISAVE M2 |
ORAL |
1-0-1 |
BBF / BD
|
2 MTHS |
|
|
8 |
LUPIMEG 1 GM |
ORAL |
1-0-1 |
ABF / AD
|
2 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL. |
| Next Visit |
: 21/Apr/2025 |
| Tests Suggested For Next Visit |
: HBA1C / FBS / PPBS > 2 MTHS |
| |
|
| |
|
Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra /
2003/05/2166
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |
|